Hypoactive Sexual Desire Disorder (HSDD) is the decrease or absence of desire for sex that causes personal distress and may lead to relationship problems.
If you're a woman at least 30 years of age with a decrease in your sexual desire, you're invited to see if you qualify for a medical research study. To qualify you must have gone through menopause or had your ovaries removed.
The purpose of the study is to determine the safety and effectiveness of LibiGel, an investigational medicine for HSDD.
Qualified participants will receive all study-related care and study medication at no cost, and may
be compensated for time and travel.
To receive more information about this study, please take a moment to complete our online survey or you may call us
directly at 817-281-4156.
Study volunteers are not required to complete this online survey in order to be considered for participation in this study.
The purpose of this online survey is for us to collect your contact information as well as a brief medical history to help determine your eligibility.
All information provided will be considered confidential and will not be shared outside of Protenium Clinical Research.
View our ad for this study
Click here to view this study's dedicated website in a new browser window.
Please list all medications you are currently taking. If possible, please list the name, dose and frequency of use for each medication.